What are practical considerations in management of the most common AEs with monoclonal antibodies?

Join Dr. Nooka as he explains how to manage patients who are experiencing adverse events with the two approved monoclonal antibodies, elotuzumab and daratumumab.

Join our online communities to begin receiving free continuing medical education (CME) credit today!